✉news TechnologyAI first seen 8 d ago, last 6 d ago, peak #1
Drugmaker CEOs Skeptical of Silicon Valley's AI Disease Cure Claims
Original: Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren’t Buying It.
A Wall Street Journal report says pharmaceutical industry leaders are pushing back against Silicon Valley claims that artificial intelligence will soon cure disease. While tech executives tout AI as a route to breakthrough medicines, drugmaker CEOs remain unconvinced, pointing to the slow, risky realities of drug development. The debate highlights growing tension between tech optimists and healthcare veterans over how quickly AI can transform medicine.
Why now: Tension between AI hype from tech leaders and pharma skepticism is resonating as AI in medicine becomes a major investment and policy topic.
Wall Street JournalSilicon Valleypharmaceutical industry
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/4822626